Your browser doesn't support javascript.
loading
Public perception of predictive cancer genetic testing and research in Oregon.
Alvord, Teala W; Marriott, Lisa K; Nguyen, Phuc T; Shafer, Autumn; Brown, Kim; Stoller, Wesley; Volpi, Jennifer L; Vandehey-Guerrero, Jill; Ferrara, Laura K; Blakesley, Steven; Solomon, Erin; Kuehl, Hannah; Palma, Amy J; Farris, Paige E; Hamman, Kelly J; Cotter, Madisen; Shannon, Jackilen.
Afiliação
  • Alvord TW; OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
  • Marriott LK; BUILD EXITO Trainee, Portland State University, Portland, OR, USA.
  • Nguyen PT; OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
  • Shafer A; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Brown K; OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
  • Stoller W; BUILD EXITO Trainee, Portland State University, Portland, OR, USA.
  • Volpi JL; School of Journalism and Communication, University of Oregon, Eugene, OR, USA.
  • Vandehey-Guerrero J; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Ferrara LK; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Blakesley S; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Solomon E; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Kuehl H; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Palma AJ; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Farris PE; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Hamman KJ; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, OR, USA.
  • Cotter M; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Shannon J; OHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR, USA.
J Genet Couns ; 29(2): 259-281, 2020 04.
Article em En | MEDLINE | ID: mdl-32220044
ABSTRACT
The potential for using widespread genetic testing to inform health care has become a viable option, particularly for heritable cancers. Yet, little is known about how to effectively communicate the benefits and risks of both personal genetic testing and participation in biorepositories that aid scientific advancements. Nationwide efforts are engaging communities in large genetic studies to better estimate the population-wide prevalence of heritable cancers but have been met with hesitance or declination to participate in some communities. To successfully engage an Oregon population in longitudinal research that includes predictive genetic testing for pathogenic or likely pathogenic variants associated with an increased risk for cancer, researchers conducted 35 focus groups (two of which were held in Spanish) in 24 of Oregon's 36 counties to better understand knowledge and attitudes related to genetic testing and willingness to participate in longitudinal genetic research. A total of 203 adults (mean = 45.6 years; range 18-88), representing a range of education levels and prior knowledge of genetic research, participated in the focus groups. The majority (85%) of participants reported personal or family diagnoses of cancer (e.g., self, family, friends). A majority (87%) also reported a strong interest in cancer genetic testing and receiving genetic information about themselves. Nearly all focus groups (94%, 33 of 35 sites) included participant discussion citing their families (e.g., children, close relatives, and extended family members) as key motivators for participation in genetic research. For example, participants reported interest in increasing personal knowledge about their own and their families' cancer risks in order to respond proactively, if a pathogenic variant was found. While most focus groups (94%, 33 of 35 sites) included participant discussion describing barriers to predictive genetic, testing such as concerns about outcomes, the desire to learn about health risks in oneself mitigated or outweighed those fears for many participants. Other commonly reported concerns were related to potential mistrust of insurance companies, researchers, or institutions, or lack of knowledge about genetics, genetic testing, or genetic research. Participants, particularly in rural areas, highlighted critical factors for research recruitment, such as trust, personal interaction, public education about genetic research, and clear communication about study goals and processes. Our statewide findings reflect that public interest in predictive cancer genetic testing and cancer genetic research can surpass lack of knowledge of the complex topics, particularly when benefits for self and family are emphasized and when study considerations are well articulated.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes Genéticos / Neoplasias Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Child / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes Genéticos / Neoplasias Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Child / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article